Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $1.62 billion. The enterprise value is $1.33 billion.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 501.11 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Current Share Class | 412.08M |
| Shares Outstanding | 501.11M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | -1.01% |
| Owned by Insiders (%) | 20.92% |
| Owned by Institutions (%) | 16.45% |
| Float | 396.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| Forward PS | 1.02 |
| PB Ratio | 4.72 |
| P/TBV Ratio | 4.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.55 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.90% and return on invested capital (ROIC) is -14.41%.
| Return on Equity (ROE) | -28.90% |
| Return on Assets (ROA) | -5.66% |
| Return on Capital (ROIC) | -14.41% |
| Revenue Per Employee | $3.83M |
| Profits Per Employee | -$165,560 |
| Employee Count | 552 |
| Asset Turnover | 2.47 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +207.62% in the last 52 weeks. The beta is 1.95, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +207.62% |
| 50-Day Moving Average | 3.59 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 45.48 |
| Average Volume (20 Days) | 4,471,835 |
Short Selling Information
The latest short interest is 15.28 million, so 3.05% of the outstanding shares have been sold short.
| Short Interest | 15.28M |
| Short Previous Month | 16.44M |
| Short % of Shares Out | 3.05% |
| Short % of Float | 3.86% |
| Short Ratio (days to cover) | 2.18 |
Income Statement
In the last 12 months, CLOV had revenue of $2.12 billion and -$91.39 million in losses. Loss per share was -$0.19.
| Revenue | 2.12B |
| Gross Profit | 330.39M |
| Operating Income | -77.55M |
| Pretax Income | -123.70M |
| Net Income | -91.39M |
| EBITDA | -77.09M |
| EBIT | -77.55M |
| Loss Per Share | -$0.19 |
Full Income StatementBalance Sheet
The company has $333.05 million in cash and $3.67 million in debt, giving a net cash position of $284.29 million or $0.57 per share.
| Cash & Cash Equivalents | 333.05M |
| Total Debt | 3.67M |
| Net Cash | 284.29M |
| Net Cash Per Share | $0.57 |
| Equity (Book Value) | 342.17M |
| Book Value Per Share | 0.68 |
| Working Capital | 153.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$108.62 million and capital expenditures -$977,000, giving a free cash flow of -$109.59 million.
| Operating Cash Flow | -108.62M |
| Capital Expenditures | -977,000 |
| Free Cash Flow | -109.59M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
Gross margin is 15.62%, with operating and profit margins of -3.67% and -4.32%.
| Gross Margin | 15.62% |
| Operating Margin | -3.67% |
| Pretax Margin | -4.54% |
| Profit Margin | -4.32% |
| EBITDA Margin | -3.64% |
| EBIT Margin | -3.67% |
| FCF Margin | n/a |